A bill for an act relating to abortions including informed consent, dispensing abortion-inducing drugs, and reporting abortion-inducing drug complications.
If enacted, SSB3115 would significantly alter current procedures surrounding abortion and the dispensing of abortion-inducing medications in the state. It would impose stricter regulations on health care providers, possibly impacting their licensing if they fail to comply with the new informed consent and reporting requirements. The bill also seeks to create a more standardized approach across the state regarding the treatment and consultation processes involved before a woman undergoes an abortion, potentially ensuring greater oversight of these medical practices.
Senate Study Bill 3115 aims to regulate the administration of abortion-inducing drugs and establish new informed consent requirements for physicians. Under this bill, a physician must conduct an in-person examination of a woman seeking an abortion and must verify whether there are signs of coercion or abuse. Additionally, before prescribing or dispensing abortion-inducing medications, the physician is required to obtain written confirmation from the woman acknowledging that she has been informed about the associated health risks, as well as how to access emergency medical care if complications arise, which does not apply in cases of medical emergencies. The bill also mandates that specific reporting requirements be followed whenever complications arise from these drugs.
There are notable points of contention surrounding SSB3115. Supporters argue that the bill serves to protect women's health and ensure they are fully informed about potential risks and alternatives associated with chemical abortions. Opponents, on the other hand, may view these requirements as an infringement on women's rights and access to reproductive health care, suggesting that such regulations could lead to unnecessary delays and complications in obtaining abortions. There are concerns that the additional regulations might disproportionately affect low-income women and those in rural areas who may already face barriers to access.
The bill also delineates a private cause of action against those who dispense abortion-inducing drugs in violation of its provisions, allowing individuals associated with a woman who underwent a chemical abortion to seek damages for any harm caused. It emphasizes the protection of patient identities by requiring that identifying information be redacted from legal documents in associated court cases, thus seeking to maintain confidentiality while also providing pathways for accountability.